CY1108138T1 - Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι - Google Patents

Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι

Info

Publication number
CY1108138T1
CY1108138T1 CY20081100628T CY081100628T CY1108138T1 CY 1108138 T1 CY1108138 T1 CY 1108138T1 CY 20081100628 T CY20081100628 T CY 20081100628T CY 081100628 T CY081100628 T CY 081100628T CY 1108138 T1 CY1108138 T1 CY 1108138T1
Authority
CY
Cyprus
Prior art keywords
treatment
conglutin gamma
lupin conglutin
lupinoconglutine
lupin
Prior art date
Application number
CY20081100628T
Other languages
English (en)
Inventor
Paolo Morazzoni
Marcello Duranti
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of CY1108138T1 publication Critical patent/CY1108138T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αποκαλύπτει τη χρησιμοποίηση γάμμα λουπινοκονγλουτίνης ή πρωτεϊνών οι οποίες παρουσιάζουν ομολογία ανωτέρα του 50% με την γάμμα λουπινοκονγλουτίνη δια την παρασκευή ενός φαρμάκου, συμπληρωμάτων τροφίμων ή τροφίμων δια την θεραπευτική αγωγή διαβήτου τύπου II. Φάρμακα και συμπληρώματα τροφίμων που περιέχουν γάμμα λουπινοκονγλουτίνη και τη χρησιμοποίηση γάμμα λουπινοκονγλουτίνης ως θεραπευτικού παράγοντος και ειδικότερα ως παράγοντος υπογλυκοποιήσεως. Η γάμμα λουπινοκονγλουτίνη μπορεί να χρησιμοποιηθεί υπό καθαρά μορφή ή υπό μορφή εκχυλισμάτων, μειγμάτων ή συμπυκνωμάτων.
CY20081100628T 2003-02-11 2008-06-12 Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι CY1108138T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000237A ITMI20030237A1 (it) 2003-02-11 2003-02-11 Uso della conglutina di lupino per il trattamento del
EP04708771A EP1605957B1 (en) 2003-02-11 2004-02-06 The use of lupin conglutin for the treatment of type ii diabetes

Publications (1)

Publication Number Publication Date
CY1108138T1 true CY1108138T1 (el) 2014-02-12

Family

ID=32866063

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100628T CY1108138T1 (el) 2003-02-11 2008-06-12 Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι

Country Status (21)

Country Link
US (1) US7323441B2 (el)
EP (1) EP1605957B1 (el)
JP (2) JP2006517212A (el)
KR (2) KR20110033312A (el)
CN (1) CN1747739B (el)
AT (1) ATE391510T1 (el)
AU (1) AU2004212297B2 (el)
CA (1) CA2515607C (el)
CY (1) CY1108138T1 (el)
DE (1) DE602004012984T2 (el)
DK (1) DK1605957T3 (el)
ES (1) ES2303937T3 (el)
HK (1) HK1085927A1 (el)
IL (1) IL170200A (el)
IT (1) ITMI20030237A1 (el)
NO (1) NO333224B1 (el)
PL (1) PL214193B1 (el)
PT (1) PT1605957E (el)
RU (1) RU2339393C2 (el)
SI (1) SI1605957T1 (el)
WO (1) WO2004071521A1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del
ES2517640T3 (es) 2008-05-30 2014-11-03 Policlinico San Donato S.P.A.- Istituto Di Ricovero E Cura A Carattere Scientifico Conglutina gamma como medicamento y suplemento dietético
PT3130396T (pt) 2009-03-27 2021-05-12 Bend Res Inc Processo de secagem por pulverização
EP2611530B1 (en) 2010-09-03 2019-01-16 Bend Research, Inc. Spray-drying apparatus and methods of using the same
US9084976B2 (en) 2010-09-03 2015-07-21 Bend Research, Inc. Spray-drying apparatus and methods of using the same
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
EA034221B1 (ru) * 2010-10-12 2020-01-17 Консуму Эм Верди - Биотекноложия Даш Планташ, С.А. Композиция на основе полипептида blad, обладающая фунгицидным и бактерицидным действием, и ее применение
WO2016000939A1 (de) * 2014-06-30 2016-01-07 Fraunhofer-Gesellschaft Zur Foerderung Der Angewanden Forschung E.V. Emulsion mit lupinenprotein
WO2016067132A1 (en) 2014-10-31 2016-05-06 Bend Research Inc. Process for forming active domains dispersed in a matrix

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin
JPH08127538A (ja) * 1994-10-31 1996-05-21 Masakiyo Takahashi 糖尿病治療薬
JPH0967252A (ja) * 1995-09-05 1997-03-11 Zenkoku Royal Jelly Kosei Torihiki Kiyougikai ローヤルゼリーに含まれるトランス−10−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del

Also Published As

Publication number Publication date
ITMI20030237A1 (it) 2004-08-12
RU2005125411A (ru) 2006-01-27
RU2339393C2 (ru) 2008-11-27
CA2515607C (en) 2013-10-15
AU2004212297B2 (en) 2009-09-10
EP1605957A1 (en) 2005-12-21
PL214193B1 (pl) 2013-06-28
CN1747739A (zh) 2006-03-15
KR20050106415A (ko) 2005-11-09
HK1085927A1 (en) 2006-09-08
KR101084434B1 (ko) 2011-11-21
JP2012153715A (ja) 2012-08-16
IL170200A (en) 2010-05-31
NO333224B1 (no) 2013-04-15
DE602004012984T2 (de) 2009-06-04
CA2515607A1 (en) 2004-08-26
ES2303937T3 (es) 2008-09-01
SI1605957T1 (sl) 2008-08-31
DE602004012984D1 (de) 2008-05-21
AU2004212297A1 (en) 2004-08-26
ATE391510T1 (de) 2008-04-15
DK1605957T3 (da) 2008-08-11
PL377578A1 (pl) 2006-02-06
WO2004071521A1 (en) 2004-08-26
US20060142185A1 (en) 2006-06-29
JP2006517212A (ja) 2006-07-20
NO20053788L (no) 2005-11-11
CN1747739B (zh) 2013-04-17
NO20053788D0 (no) 2005-08-10
JP5504301B2 (ja) 2014-05-28
US7323441B2 (en) 2008-01-29
PT1605957E (pt) 2008-06-27
EP1605957B1 (en) 2008-04-09
KR20110033312A (ko) 2011-03-30

Similar Documents

Publication Publication Date Title
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
MX2008004734A (es) Composicion rica en leucina.
WO2001028356A3 (en) Food supplement for increasing lean mass and strength
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
IL135335A0 (en) Method for inhibiting or preventing hormone induced adverse effects and novel pharmaceutical compositions comprising carotenoids
IL172898A0 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
MXPA02011476A (es) Fuente de triptofano de plantas y usos para el mismo.
DE60012301D1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
TW200513197A (en) Amino acid supplementation for a healthy microbiota ecosystem
BRPI0410761A (pt) uso de leucina, e, composição para administração entérica a pacientes
WO2002089741A3 (en) Compositions and methods for enhancing drug delivery
AR045745A1 (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2
TW200501973A (en) Method of improvement of blood circulation
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
JP2017043593A (ja) 黒ニンニク及びビタミンb1を含有する組成物
MX2022013214A (es) Metodos para aumentar el flujo sanguineo microvascular.
WO2003101387A3 (en) Globulin protein to lower cholesterol in humans
NZ512402A (en) Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale
LT2001072A (lt) Maisto papildas
LT2001054A (lt) Propolio tepalas
TH87926A (th) โภชนาการสำหรับผู้ป่วยอ้วนเกิน
RU2003106768A (ru) Способ лечебного питания больных хроническим панкреатитом